Document Detail

Direct renin inhibitors: a new approach to antihypertensive drug treatment.
MedLine Citation:
PMID:  17673883     Owner:  NLM     Status:  MEDLINE    
Hypertension remains a leading cause of morbidity and mortality, affecting more than 60 million persons in the United States. Although the past 5 decades have witnessed advances in the therapeutic modalities available to treat hypertension and a dramatic decrease in morbidity and mortality related to hypertension, adequate blood pressure control has still not been achieved in a large number of patients. Therapeutic options to manage hypertension include agents that block the sympathetic nervous system, vasodilators, agents to control plasma volume, and drugs that act at various points in the renin-angiotensin system (RAS). Inadequate control of hypertension may be due in part to incomplete blockade of the RAS pathway in some patients; targeting a point earlier in this cascade might possibly improve control. Direct renin inhibitors, a new class of antihypertensive drugs, block the RAS pathway at the point of activation. Inhibition of renin prevents the downstream production of the potent vasoconstrictor angiotensin II, which is responsible for increasing blood pressure. Recent clinical data with aliskiren, a new direct renin inhibitor, suggest favorable results in patients with hypertension and a possible new treatment option.
C Venkata S Ram
Related Documents :
2652313 - Renovascular hypertension: etiology and pathophysiology.
6100873 - The role of the renin-angiotensin system in blood pressure regulation in normotensive a...
3993563 - Echocardiographic versus hemodynamic monitoring during attacks of variant angina pectoris.
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Journal of clinical hypertension (Greenwich, Conn.)     Volume:  9     ISSN:  1524-6175     ISO Abbreviation:  J Clin Hypertens (Greenwich)     Publication Date:  2007 Aug 
Date Detail:
Created Date:  2007-08-03     Completed Date:  2007-10-16     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  100888554     Medline TA:  J Clin Hypertens (Greenwich)     Country:  United States    
Other Details:
Languages:  eng     Pagination:  615-21     Citation Subset:  IM    
Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX 75240, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Antihypertensive Agents / adverse effects,  pharmacology,  therapeutic use*
Blood Pressure / drug effects
Hypertension / drug therapy*
Renin / antagonists & inhibitors*,  drug effects
Renin-Angiotensin System / drug effects*
Reg. No./Substance:
0/Antihypertensive Agents; EC

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Use of endovascular stents in atherosclerotic renovascular stenosis: blood pressure and renal functi...
Next Document:  Statins and C-reactive protein levels.